OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024 More prescriptions ...

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024 More prescriptions filled through February 2025 than in Q4 2024 Over 4,600 unique prescribers wit ...

Discover why doctors warn against vaping for people with these five health conditions including asthma, heart disease, and ...

A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...

Early speculations about Gene Hackman's death included the possibility of carbon monoxide poisoning. Here's how to prevent ...

Extreme heat can impair cognitive function, leading to disorientation. It may equally increase the risk of mental health ...

TBPH's fourth-quarter earnings match estimates while sales beat the same marginally. Increased collaboration revenues from ...

While many other retail giants have pulled back on their recent forays into health care, Best Buy (NYSE: BBY) is continuing ...

A higher comorbidity burden was linked to an increased rate of adverse events as well as early discontinuation among patients ...

In the evening medical bulletin of the Gemelli hospital, it is reported that the clinical conditions of Pope Francis continue ...

In India, a few exceptional residential facilities are redefining eldercare with personalized attention, expert-led therapies ...